138 related articles for article (PubMed ID: 11829024)
21. Regulation of body fluid compartments during short-term spaceflight.
Leach CS; Alfrey CP; Suki WN; Leonard JI; Rambaut PC; Inners LD; Smith SM; Lane HW; Krauhs JM
J Appl Physiol (1985); 1996 Jul; 81(1):105-16. PubMed ID: 8828652
[TBL] [Abstract][Full Text] [Related]
22. [Study on space motion sickness before, during and after spaceflight].
Wang LJ; Zhang D; Dong WJ
Space Med Med Eng (Beijing); 2003 Oct; 16(5):382-6. PubMed ID: 14753243
[TBL] [Abstract][Full Text] [Related]
23. Pharmaceutical countermeasures have opposite effects on the utricles and semicircular canals in man.
Weerts AP; De Meyer G; Pauwels G; Vanspauwen R; Dornhoffer JL; Van de Heyning PH; Wuyts FL
Audiol Neurootol; 2012; 17(4):235-42. PubMed ID: 22517315
[TBL] [Abstract][Full Text] [Related]
24. The Combination of Scopolamine and Psychostimulants for the Prevention of Severe Motion Sickness.
Zhang LL; Liu HQ; Yu XH; Zhang Y; Tian JS; Song XR; Han B; Liu AJ
CNS Neurosci Ther; 2016 Aug; 22(8):715-22. PubMed ID: 27160425
[TBL] [Abstract][Full Text] [Related]
25. Various anti-motion sickness drugs and core body temperature changes.
Cheung B; Nakashima AM; Hofer KD
Aviat Space Environ Med; 2011 Apr; 82(4):409-15. PubMed ID: 21485398
[TBL] [Abstract][Full Text] [Related]
26. Plasma and urine catecholamine levels in cosmonauts during long-term stay on Space Station Salyut-7.
Kvetnansky R; Davydova NA; Noskov VB; Vigas M; Popova IA; Usakov AC; Macho L; Grigoriev AI
Acta Astronaut; 1988 Feb; 17(2):181-6. PubMed ID: 11542424
[TBL] [Abstract][Full Text] [Related]
27. Free fall: a partial unique motion environment.
Graybiel A
Acta Astronaut; 1980 Dec; 7(12):1477-81. PubMed ID: 11541658
[TBL] [Abstract][Full Text] [Related]
28. Relative bioavailability of scopolamine dosage forms and interaction with dextroamphetamine.
Boyd JL; Du B; Vaksman Z; Locke JP; Putcha L
J Gravit Physiol; 2007 Jul; 14(1):P107-8. PubMed ID: 18372722
[TBL] [Abstract][Full Text] [Related]
29. Vestibular factors influencing the biomedical support of humans in space.
Lichtenberg BK
Acta Astronaut; 1988; 17(2):203-6. PubMed ID: 11537098
[TBL] [Abstract][Full Text] [Related]
30. Comparison of efficacy of ginger with various antimotion sickness drugs.
Wood CD; Manno JE; Wood MJ; Manno BR; Mims ME
Clin Res Pr Drug Regul Aff; 1988; 6(2):129-36. PubMed ID: 11538042
[TBL] [Abstract][Full Text] [Related]
31. Investigation of anti-motion sickness drugs in the squirrel monkey.
Cheung BS; Money KE; Kohl RL; Kinter LB
J Clin Pharmacol; 1992 Feb; 32(2):163-75. PubMed ID: 1613127
[TBL] [Abstract][Full Text] [Related]
32. Mineral and nitrogen balance study: results of metabolic observations on Skylab II 28-day orbital mission.
Whedon GD; Lutwak L; Reid J; Rambaut P; Whittle M; Smith M; Leach C
Acta Astronaut; 1975; 2(3-4):297-309. PubMed ID: 11887918
[TBL] [Abstract][Full Text] [Related]
33. What you thought you knew about motion sickness isn't necessarily so.
Cowings PS; Malmstrom FV
Flying Saf; 1984 Feb; 40(2):12-7. PubMed ID: 11540877
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of antimotion sickness drugs.
Wood CD; Manno JE; Wood MJ; Manno BR; Redetzki HM
Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
[TBL] [Abstract][Full Text] [Related]
35. Pharmacotherapeutics in space.
Putcha L
J Gravit Physiol; 1999 Jul; 6(1):P165-8. PubMed ID: 11543005
[TBL] [Abstract][Full Text] [Related]
36. The use of medicaments in space--therapeutic measures and potential impact of pharmacokinetics due to weightlessness.
Pavy-Le Traon A; Guell A; Saivin S; Houin G; Soulez-Lariviere C; Pujos M
ESA J; 1994; 18(1):33-50. PubMed ID: 11541451
[TBL] [Abstract][Full Text] [Related]
37. Biomedical results of the Skylab Program.
Michel EL; Johnston RS; Dietlein LF
Life Sci Space Res; 1976; 14():3-18. PubMed ID: 11977284
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate.
Golding JF; Stott JR
Br J Clin Pharmacol; 1997 Jun; 43(6):633-7. PubMed ID: 9205824
[TBL] [Abstract][Full Text] [Related]
39. The effect of antimotion sickness drugs on habituation to motion.
Wood CD; Manno JE; Manno BR; Odenheimer RC; Bairnsfather LE
Aviat Space Environ Med; 1986 Jun; 57(6):539-42. PubMed ID: 3718377
[TBL] [Abstract][Full Text] [Related]
40. Visual side effects of scopolamine/ dextroamphetamine among parabolic fliers.
Makowski AL; Lindgren K; Locke JP
Aviat Space Environ Med; 2011 Jul; 82(7):683-8. PubMed ID: 21748905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
